4.7 Article

Predictors and Consequences of Sac Shrinkage after Endovascular Infrarenal Aortic Aneurysm Repair

期刊

JOURNAL OF CLINICAL MEDICINE
卷 11, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/jcm11113232

关键词

abdominal aortic aneurysms; endovascular aneurysm repair (EVAR); Endurant; sac shrinkage; predictive factors

向作者/读者索取更多资源

This study found that shrinkage of the aneurysm sac is not significantly associated with improved survival rates or reduced risk of secondary interventions. Regardless of shrinkage, the risk of secondary interventions seems to be more closely linked to compliance with the instructions for use.
Background: Aneurysm shrinkage has been proposed as a marker of successful endovascular aneurysm repair (EVAR). We evaluated the impact of sac shrinkage on secondary interventions, on survival and its association with endoleaks, and on compliance with instructions for use (IFU). Methods: This observational retrospective study was conducted on all consecutive patients receiving EVAR for an infrarenal abdominal aortic aneurysm (AAA) using exclusively Endurant II/IIs endograft from 2014 to 2018. Sixty patients were entered in the study. Aneurysm sac shrinkage was defined as decrease >= 5 mm of the maximum aortic diameter. Univariate methods and Kaplan-Meier plots assessed the potential impact of shrinkage. Results: Twenty-six patients (43.3%) experienced shrinkage at one year, and thirty-four (56.7%) had no shrinkage. Shrinkage was not significantly associated with any demographics or morbidity, except hypertension (p = 0.01). No aneurysm characteristics were associated with shrinkage. Non-compliance with instructions for use (IFU) in 13 patients (21.6%) was not associated with shrinkage. Three years after EVAR, freedom from secondary intervention was 85 +/- 2% for the entire series, 92.3 +/- 5.0% for the shrinkage group and 83.3 +/- 9% for the no-shrinkage group (Logrank: p = 0.49). Survival at 3 years was not significantly different between the two groups (85.9 +/- 7.0% vs. 79.0 +/- 9.0%, Logrank; p = 0.59). Strict compliance with IFU was associated with less reinterventions at 3 years (92.1 +/- 5.9% vs. 73.8 +/- 15%, Logrank: p = 0.03). Similarly, survival at 3 years did not significantly differ between strict compliance with IFU and non-compliance (81.8 +/- 7.0% vs. 78.6 +/- 13.0%, Logrank; p = 0.32). Conclusion: This study suggests that shrinkage >= 5 mm at 1-year is not significantly associated with a better survival rate or a lower risk of secondary intervention than no-shrinkage. In this series, the risk of secondary intervention regardless of shrinkage seems to be linked more to non-compliance with IFU. Considering the small number of patients, these results must be confirmed by extensive prospective studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据